Showing results (171-180 of 559) with videos related to
Sort By:
Pageof 56
Circulation|May 25, 2011
Predictors of bleeding and time dependence of association of bleeding with mortality: insights from the Trial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet Inhibition With Prasugrel--Thrombolysis in Myocardial Infarction 38 (TRITON-TIMI 38)Willibald Hochholzer, Stephen D Wiviott, Elliott M Antman, et al.Journal of the American College of Cardiology|March 5, 2021
Randomized, Double-Blind Comparison of Half-Dose Versus Full-Dose Edoxaban in 14,014 Patients With Atrial FibrillationJan Steffel, Christian T Ruff, Ophelia Yin, et al.Journal of the American Heart Association|February 25, 2016
Concomitant Use of Single Antiplatelet Therapy With Edoxaban or Warfarin in Patients With Atrial Fibrillation: Analysis From the ENGAGE AF-TIMI48 TrialHaiyan Xu, Christian T Ruff, Robert P Giugliano, et al.Journal of the American College of Cardiology|December 4, 2014
New ischemic stroke and outcomes with vorapaxar versus placebo: results from the TRA 2 °P-TIMI 50 trialMarc P Bonaca, Benjamin M Scirica, Eugene Braunwald, et al.Circulation|May 22, 2002
Safety and tolerability of pravastatin in long-term clinical trials: prospective Pravastatin Pooling (PPP) ProjectMarc A Pfeffer, Anthony Keech, Frank M Sacks, et al.Circulation. Cardiovascular Quality and Outcomes|November 5, 2020
Cardiovascular- and Bleeding-Related Hospitalization Rates With Edoxaban Versus Warfarin in Patients With Atrial Fibrillation Based on Results of the ENGAGE AF-TIMI 48 TrialKatherine Vilain, Haiyan Li, Wingham J Kwong, et al.Circulation|April 13, 2005
Association of hemoglobin levels with clinical outcomes in acute coronary syndromesMarc S Sabatine, David A Morrow, Robert P Giugliano, et al.Journal of the American College of Cardiology|November 16, 2004
Acute changes in circulating natriuretic peptide levels in relation to myocardial ischemiaMarc S Sabatine, David A Morrow, James A de Lemos, et al.The American Journal of Cardiology|January 27, 2005
Association of culprit lesion calcium with angiographic and clinical outcomes in patients with ST-elevation myocardial infarction treated with fibrinolytic therapyAjay J Kirtane, Ioanna Kosmidou, Dimitrios Karmpaliotis, et al.The American Journal of Cardiology|September 22, 2007
Effect of intensive lipid-lowering therapy on mortality after acute coronary syndrome (a patient-level analysis of the Aggrastat to Zocor and Pravastatin or Atorvastatin Evaluation and Infection Therapy-Thrombolysis in Myocardial Infarction 22 trials)Sabina A Murphy, Christopher P Cannon, Stephen D Wiviott, et al.Pageof 56